479 results on '"Lloyd, Shane"'
Search Results
2. Risk-Adapted Intraoperative Radiation Therapy (IORT) for Breast Cancer: A Novel Analysis
3. ASO Author Reflections: Intraoperative Radiation Therapy (IORT): Will It Survive in the USA?
4. Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults
5. ASO Visual Abstract: Risk-Adapted Intraoperative Radiation Therapy (IORT) for Breast Cancer—Novel Analysis
6. The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer
7. The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients
8. Capturing Chemotherapy and Radiotherapy Dose Among Breast Cancer Patients With the Utah All‐Payer Claims Database Compared With Gold‐Standard Abstraction.
9. The Effect of Maximum Tumor Diameter by MRI on Disease Control in Intermediate and High-risk Prostate Cancer Patients Treated With Brachytherapy Boost
10. Temporal Trends and Predictors in Diagnosing Pathologic Node-Positive Prostate Cancer in Clinically Node-Negative Patients
11. The Effect of Measured Radiotherapy Dose on Intrathecal Drug Delivery System Function
12. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome
13. Racial and Ethnic Health Disparities in Delay to Initiation of Intensity-Modulated Radiotherapy
14. Determining the association of rurality and cardiovascular disease among prostate cancer survivors
15. Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality Radiotherapy
16. Analysis of Nonsurgical Treatment Options for Metastatic Rectal Cancer
17. COMPARING ACTIVE SURVEILLANCE AND WATCHFUL WAITING AND RADICAL TREATMENT USING MACHINE LEARNING MODELS AMONG PROSTATE CANCER PATIENTS
18. The efficacy-associated biomarkers for immune checkpoint inhibitors in gastrointestinal cancer: a literature review
19. Refusal of Local Therapy in Esophageal Cancer and Impact on Overall Survival
20. ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer
21. Lymph Node Ratio in Pancreatic Adenocarcinoma After Preoperative Chemotherapy vs. Preoperative Chemoradiation and Its Utility in Decisions About Postoperative Chemotherapy
22. Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides
23. Adverse health outcomes among rural prostate cancer survivors: A population-based study
24. Adjuvant radiation for T1-2N1 oral cavity cancer survival outcomes and utilization treatment trends: Analysis of the SEER database
25. Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy
26. Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins
27. Correlates of Refusal of Surgery in the Treatment of Non-metastatic Pancreatic Adenocarcinoma
28. Comparing Active Surveillance and Watchful Waiting With Radical Treatment Using Machine Learning Models Among Patients With Prostate Cancer
29. Adverse Health Outcomes Among Rural And Urban Breast Cancer Survivors: A Population-Based Cohort Study
30. ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II
31. ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer
32. ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II
33. Mental health outcomes in a population-based cohort of patients with prostate cancer.
34. NEXT: A phase 2 study of nivolumab adjuvant to chemoradiation in patients (pts) with localized urothelial carcinoma.
35. Endocrine and metabolic diseases among survivors of prostate cancer in a population-based cohort.
36. Rural-urban disparities in prostate cancer survival: A population-based study.
37. Mature results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naïve men with oligometastatic prostate cancer to bone.
38. Factors predictive of neoadjuvant versus adjuvant chemoradiotherapy in locally advanced rectal cancer and the impact on overall survival
39. A comprehensive analysis of clinical trials including both immunotherapy and radiation therapy
40. Adipose Tissue Distribution and Body Mass Index (BMI) Correlation With Daily Image-Guided Radiotherapy (IGRT) Shifts of Abdominal Radiation Therapy Patients
41. Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials
42. PD21-05 CARDIOVASCULAR OUTCOMES IN A POPULATION-BASED COHORT OF PROSTATE CANCER PATIENTS
43. A comprehensive analysis of brachytherapy clinical trials over the past 15 years
44. The “decay” of brachytherapy use in tumors of the oral cavity: A population-based patterns of care and outcomes analysis from 1973 to 2012
45. Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival
46. Initial results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naïve men with oligometastatic prostate cancer to bone.
47. Osteoprotegerin is an effective countermeasure for spaceflight-induced bone loss in mice
48. Changes in brachytherapy-based APBI patient selection immediately before and after publication of the ASTRO consensus statement
49. Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched Analysis
50. Pelvic Reirradiation for the Treatment of Locally Recurrent Rectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.